Cochrane Abstracts
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Biologic or Tofacitinib Monotherapy for Rheumatoid Arthritis in People With Traditional Disease‐modifying Anti‐rheumatic Drug (DMARD) Failure: a Cochrane Systematic Review and Network Meta‐analysis (NMA)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434773/0/Biologic_or_tofacitinib_monotherapy_for_rheumatoid_arthritis_in_people_with_traditional_disease‐modifying_anti‐rheumatic_drug__DMARD__failure:_a_Cochrane_Systematic_Review_and_network_meta‐analysis__NMA_. Accessed 15 September 2024.
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434773/0/Biologic_or_tofacitinib_monotherapy_for_rheumatoid_arthritis_in_people_with_traditional_disease‐modifying_anti‐rheumatic_drug__DMARD__failure:_a_Cochrane_Systematic_Review_and_network_meta‐analysis__NMA_. Accessed September 15, 2024.
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434773/0/Biologic_or_tofacitinib_monotherapy_for_rheumatoid_arthritis_in_people_with_traditional_disease‐modifying_anti‐rheumatic_drug__DMARD__failure:_a_Cochrane_Systematic_Review_and_network_meta‐analysis__NMA_
Biologic or Tofacitinib Monotherapy for Rheumatoid Arthritis in People With Traditional Disease‐modifying Anti‐rheumatic Drug (DMARD) Failure: a Cochrane Systematic Review and Network Meta‐analysis (NMA) [Internet]. In: Cochrane Abstracts. [cited 2024 September 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434773/0/Biologic_or_tofacitinib_monotherapy_for_rheumatoid_arthritis_in_people_with_traditional_disease‐modifying_anti‐rheumatic_drug__DMARD__failure:_a_Cochrane_Systematic_Review_and_network_meta‐analysis__NMA_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
ID - 434773
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434773/0/Biologic_or_tofacitinib_monotherapy_for_rheumatoid_arthritis_in_people_with_traditional_disease‐modifying_anti‐rheumatic_drug__DMARD__failure:_a_Cochrane_Systematic_Review_and_network_meta‐analysis__NMA_
DB - Evidence Central
DP - Unbound Medicine
ER -
